Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rac1 GTPase Regulates the SCF<sup>βTrCP</sup>-Mediated Degradation of Claspin and the Cellular Response of Pancreatic Cancer Cells to Gamma Rays.

Cancers·2026
Same author

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases.

Nature communications·2026
Same author

Orai1 is required for Ca<sup>2+</sup>-dependent plasma membrane repair and mechanoadaptation.

bioRxiv : the preprint server for biology·2026
Same author

Estradiol Reprograms Microglia to Create an Immune-Suppressed Niche Permissive to Breast Cancer Brain Metastasis.

bioRxiv : the preprint server for biology·2026
Same author

Morular Metaplasia in Fundic Gland Polyps-A Case Report of a Rare Finding in a Common Lesion.

Case reports in pathology·2026

Related Experiment Video

Updated: Jun 3, 2025

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.4K

Mucin 5AC Promotes Breast Cancer Brain Metastasis through cMET/CD44v6.

Shailendra Kumar Maurya1, Jenny A Jaramillo-Gómez2, Asad Ur Rehman1

  • 1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 6, 2025
PubMed
Summary

Mucin 5AC (MUC5AC) is upregulated in breast cancer brain metastasis and drives tumor spread via the cMET/CD44v6 pathway. Targeting this axis with bozitinib offers a novel therapeutic strategy for this condition.

More Related Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.2K
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

40.9K

Related Experiment Videos

Last Updated: Jun 3, 2025

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.4K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.2K
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

40.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis Research

Background:

  • Breast cancer brain metastasis is a major clinical challenge.
  • The role of mucins, specifically mucin 5AC (MUC5AC), in this process is not well understood.

Purpose of the Study:

  • To investigate the role of MUC5AC in breast cancer brain metastasis.
  • To identify potential therapeutic targets within the MUC5AC pathway.

Main Methods:

  • In silico transcriptomic analysis of patient data.
  • RNA-sequence profiling of patient samples and cell lines.
  • In vitro and in vivo functional assays, including cell migration and adhesion studies.
  • Coimmunoprecipitation to identify protein interactions.
  • Treatment with cMET inhibitor bozitinib in a mouse model.

Main Results:

  • MUC5AC is significantly upregulated in breast cancer brain metastasis and associated with poor survival in HER2+ subtypes.
  • Elevated MUC5AC levels were detected in patient sera.
  • MUC5AC silencing reduced cell migration and brain metastasis in vivo.
  • MUC5AC promotes metastasis via the cMET/CD44v6 axis, activated by hepatocyte growth factor signaling.
  • Bozitinib effectively inhibited breast cancer brain metastasis by targeting this axis.

Conclusions:

  • The MUC5AC/cMET/CD44v6 axis is crucial for breast cancer brain metastasis.
  • Targeting this axis represents a novel therapeutic strategy for managing breast cancer brain metastasis.